Filtros : "CAPELOZZI, VERA LUIZA" "Systemic Sclerosis World Congress" Limpar

Filtros



Refine with date range


  • Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM

    Subjects: IMUNOLOGIA CELULAR, SISTÊMICO ESCLERODERMA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VELOSA, A. Pereira et al. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8196. Acesso em: 06 jun. 2024. , 2014
    • APA

      Velosa, A. P., Paiva, M. A., Andrade, P. C., Rangel, M. P., Christmann, R. B., Eher, E. M., et al. (2014). Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8196
    • NLM

      Velosa AP, Paiva MA, Andrade PC, Rangel MP, Christmann RB, Eher EM, Fernezlian SM, Parra ER, Teodoro WR, Capelozzi VL. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27-S28.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
    • Vancouver

      Velosa AP, Paiva MA, Andrade PC, Rangel MP, Christmann RB, Eher EM, Fernezlian SM, Parra ER, Teodoro WR, Capelozzi VL. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27-S28.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
  • Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM

    Subjects: FEBRE PULMONAR, COLÁGENO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINS, V. et al. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8196. Acesso em: 06 jun. 2024. , 2014
    • APA

      Martins, V., Lopes, D. B., Antunes, M., Velosa, A. P. P., Teodoro, W. R., Parra, E. R., & Capelozzi, V. L. (2014). Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8196
    • NLM

      Martins V, Lopes DB, Antunes M, Velosa APP, Teodoro WR, Parra ER, Capelozzi VL. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
    • Vancouver

      Martins V, Lopes DB, Antunes M, Velosa APP, Teodoro WR, Parra ER, Capelozzi VL. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
  • Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidades: FM, ICB

    Subjects: IMUNOLOGIA, EXPRESÃO GÊNICA, COLÁGENO, SISTÊMICO ESCLERODERMA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 06 jun. 2024. , 2014
    • APA

      Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
    • NLM

      Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
    • Vancouver

      Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 jun. 06 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024